Allakos Inc (NASDAQ:ALLK)
| 128.51 Delayed Data As of Jan 15 |  -0.04 / -0.03%Today’s Change | 41.61 Today|||52-Week Range 157.96 | -8.21% Year-to-Date |
Latest ALLK News | Press Releases
| Are Options Traders Betting on a Big Move in Allakos (ALLK) Stock? Jan 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 128.55 |
| Today’s open | 123.76 |
| Day’s range | 128.30 - 131.41 |
| Volume | 12,711 |
| Average volume (3 months) | 271,917 |
| Market cap | $6.7B |
Data as of 4:00pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +13.94% |
| Earnings growth (this year) | -65.21% |
| Earnings growth (next 5 years) | -10.55% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 12.62 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TGTXTG Therapeutics Inc | -1.52 | -2.97% |
| ---- | ||
| GLPGGalapagos NV | -1.71 | -1.68% |
| SRPTSarepta Therapeutics... | +0.50 | +0.56% |
Data as of 7:50pm ET, 01/15/2021
Financials
| Next reporting date | March 18, 2021 |
| EPS forecast (this quarter) | -$0.86 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$85.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
